Par Health Issues Voluntary Nationwide Recall Of Argatroban Injection Due To The Presence Of Particulate Matter
- Recalling firm
- Par Health
- Product
- Argatroban Injection
- Reason
- FOR IMMEDIATE RELEASE - ROCHESTER, MI– October 13, 2026 – Par Health is recalling 22 lots of Argatroban Injection 250 mg/2.5 mL (100 mg/mL) to the hospital/user level. This recall is being conducted due to the presence of particulate matter, identified as cellulose, polystyrene, polyethylene terepht
- Category
- drug recall
- Country
- United States
- Agency
- FDA-MEDWATCH-RSS
- Recall date
- 2026-10-14
- Status
- Ongoing
Official recall notice from FDA-MEDWATCH-RSS
Recall details on Nibble Recalls: https://trynibble.app/recalls/d8e5646e-daf8-4663-90c7-66a840b5c3d3